Deprenyl and levodopa and Parkinson's disease progression.
Fowler
J S
JS
Fazzini
E
E
Volkow
N D
ND
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008995:Monoamine Oxidase / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa; D008995:Monoamine Oxidase